D'Orazio & Associates’s CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) CYNA Stock Holding History

D'Orazio & Associates’s Portfolio CYNA Stock Details CYNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-62	Closed	-$2K	–	299
2016 Q3	$2K	Hold	62	–	–	﹤0.01%	267
2016 Q2	$1K	Hold	62	–	–	﹤0.01%	288
2016 Q1	$0	Buy	+62	New	+$830	﹤0.01%	326

D'Orazio & Associates's CYNA Position: Q4 2016 in Review

D'Orazio & Associates sold out of CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) (CYNA) in Q4 2016, closing a stake of 62 shares — an estimated $2K sold.

D'Orazio & Associates first reported a position in CYNA in Q1 2016 and held it in 3 quarters. The position peaked at $2K in Q3 2016. 0 funds tracked by Wall St. Rank hold CYNA as of Q4 2016.

D'Orazio & Associates reported no remaining CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) position as of Q4 2016 after selling out during the quarter.
D'Orazio & Associates sold 62 CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) shares in Q4 2016, an estimated $2K.
D'Orazio & Associates first reported a position in CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) in Q1 2016 and held it in 3 quarters.
D'Orazio & Associates's CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) position peaked at $2K in Q3 2016.
0 funds tracked by Wall St. Rank held CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) as of Q4 2016.

Based on D'Orazio & Associates's 13F filing for Q4 2016, filed 15 Feb 2017.